Articles on Medetomidine

Displaying all articles

Patients who received 17 to 24 milligrams per day of buprenorphine stayed in treatment significantly longer than those who received 16 milligrams or less, researchers found. AP Photo/Julio Cortez

Higher buprenorphine doses help patients stay in opioid use disorder treatment, new study finds

Black patients were less likely to receive higher doses. This may reflect inequities in health care or misconceptions among patients that higher doses are unsafe.
In March 2023, the U.S. Food and Drug Administration approved naloxone as a nonprescription nasal spray to reverse the effects of an opioid overdose. Michael Siluk/UCG/Universal Images Group via Getty Images

Animal tranquilizers found in illegal opioids may suppress the lifesaving medication naloxone − and cause more overdose deaths

Increasingly, these types of tranquilizers are turning up in fentanyl, oxycodone and other illegal opioids.

Top contributors

More